Details

---

• Active Ingredient: Insulin glulisine 100 units/mL

• Manufacturer: Sanofi-Aventis

• Distributor in Malaysia: Zuellig Pharma

• MAL registration number: MAL20081842AZ

Content

Each pre-filled pen contains insulin glulisine, a rapid-acting insulin analog, along with inactive ingredients.

Indications

• Management of elevated blood glucose levels in individuals with diabetes mellitus (type 1 and type 2)

• Administered via subcutaneous injection or continuous subcutaneous insulin infusion

• Should be used in conjunction with a comprehensive diabetes management plan, including diet and exercise
  
   

  Instructions for Use

• Dosage: Individualized based on blood glucose monitoring and physician's recommendations

• Administration: Inject subcutaneously into the fatty tissue of the abdomen or thigh

• Timing: Administer within 15 minutes before or immediately after meals

• Storage:

  • Unopened pens: Store in a refrigerator between 2°C and 8°C (36°F and 46°F)

  • Opened pens: Store at room temperature (below 25°C) and use within 28 days

  • Do not freeze; discard if frozen